🔗 Share this article

A shadow market for unapproved weight-loss drugs is being driven by TikTok fitness influencers and vendors on communication apps, based on new investigations.

Investigational Treatment Gaining Traction Via Social Media

The experimental drug, which is still in research studies, is being promoted by social media influencers for its supposed weight-reducing properties. Viewers are urged to contact these accounts privately for source information, while also receiving discount codes.

Thriving Trade on Social Networks

Additionally, a robust trade exists on Telegram, where groups with thousands of participants share “before and after” images, administration instructions and claims of rapid UK delivery. Vendors promote the drug there before directing customers to other platforms for purchases.

Learning About The Experimental Drug

This medication is an investigational injection developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could help individuals reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.

Healthcare Experts Express Concerns

However, physicians and pharmacists have cautions that the distribution of what is still an unlicensed medication in the United Kingdom is worrisome and could result in users administering substances of uncertain source.

Some professionals said the popularity for retatrutide could be connected to the increasing price of licensed slimming products such as Mounjaro.

Legal Status and Implementation

Marketing the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that cannot be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.

Several influencers attempt to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still violate pharmaceutical, marketing, and consumer laws, potentially leading to fines, prosecution or prison.

Service Reaction and Content Elimination

Based on TikTok, the platform has taken down violative material and banned associated keywords and search suggestions. The organization stated it was committed to maintaining the service safe and allocating resources in enhancing compliance measures.

Online Trading Operations

Research also found communities with up to 9,000 participants selling the experimental drug using the platform's integrated discovery tool, which functions like a online catalog. Entering “retatrutide” immediately brings up channels with thousands of members, populated with photos of slimming results, positive reviews and step-by-step guides for preparing or administering at home.

Within moments of joining one community, a vendor posted contact information, where most transactions occur. The seller sent an instruction manual and guaranteed shipping within two days. When questioned whether the substance was authentic, one seller said: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. Not one inquired about weight, medical conditions or past usage.

Item Details and Costs

Inside these groups, messages show black plastic packages with postal service labels, claiming to include new batches. One message read: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, mixed at home with sterile water, or ready-to-use pens typically sold at £160 for 20mg. When questioned how much time a injector should last, vendors give conflicting responses ranging from a few weeks to “depends on your body”.

Platform Moderation and Safety Actions

A spokesperson for Telegram said it regularly moderated harmful content on its platform including material that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are administering substances they cannot confirm. Even if the research behind this drug is valid, these online products may not contain what they claim,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.

A medical professional of an online medical service linked the increase in demand to recent cost increases for authorized weight-loss medications such as Mounjaro. “With prices increasing, individuals are turning to social media. But counterfeit treatments are extremely risky. You cannot know what’s inside or whether the conditions they were made in was clean,” she said.

Her team has previously encountered patients injured by self-injection from unconfirmed suppliers. “We understand the disappointment, but purchasing from Telegram or communication platforms is taking chances with your health,” stated the doctor. “These materials could be contaminated or incorrectly dosed.”

Producer Position

A spokesperson from Eli Lilly said retatrutide was in phase 3 research studies and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this point no one can market [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a company experimental product not yet approved … may expose patients to possibly serious medical dangers”.